WEBINARS AND EVENTS Elevating High-Risk Breast Cancer Care: The Impact of MyRisk® Hereditary Cancer Test with RiskScore® Speakers: Barry Rosen MD, FACS TinaMarie Bauman RN, MSN, APN, ARNP, AGN-BC, ACGN Date: 10/30/2025 Duration: 1 hour CEU: No Elevating High-Risk Breast Cancer Care: The Impact of MyRisk® Hereditary Cancer Test with RiskScore® Join us for an expert-led discussion on how the MyRisk Test with RiskScore enhances hereditary cancer risk assessment and supports the development of high-risk breast cancer clinics. This session will explore practical strategies for implementing a Breast Cancer Risk Assessment (BCRA) program, featuring real-world insights from breast surgeon, Barry Rosen, MD, FACS and TinaMarie Bauman, RN, APN, AGN-BC, ACGN, both from Advocate Good Shepherd Hospital in Greater Chicago. Learn how the Myriad Oncology™ suite of services and workflow solutions, along with the MyRisk Test with RiskScore, empower clinicians to identify high-risk, unaffected patients earlier and streamline care pathways for improved outcomes. Describe the importance of risk assessment and genetic testing to stratify a patient’s breast cancer risk Discuss MyRisk with RiskScore Test to enhance hereditary cancer risk assessment Review tools and resources for clinicians to identify high-risk, unaffected patients earlier and streamline care pathways for improved outcomes Hear from our Speakers Barry Rosen MD, FACS TinaMarie Bauman RN, MSN, APN, ARNP, AGN-BC, ACGN